Dendritic Cells Currently under the Spotlight; Classification and Subset Based upon New Markers

Immunol Invest. 2021 Aug;50(6):646-661. doi: 10.1080/08820139.2020.1783289. Epub 2020 Jun 29.

Abstract

Dendritic cells (DCs) are considered as a subset of mononuclear phagocytes that composed of multiple subsets with distinct phenotypic features. DCs play crucial roles in the initiation and modulation of immune responses to both allo- and auto-antigens during pathogenic settings, encompassing infectious diseases, cancer, autoimmunity, transplantation, as well as vaccination. DCs play a role in preventing autoimmunity via inducing tolerance to self-antigens. This review focus on the most common subsets of DCs in human. Owing to the low frequencies of DC cells in blood and tissues and also the lack of specific DC markers, studies of DCs have been greatly hindered. Human DCs arise by a dedicated pathway of lympho-myeloid hematopoiesis and give rise into specialized subtypes under the influence of transcription factors that are specific for each linage. In humans, the classification of DCs has been generally separated into the blood and cutaneous subsets, mainly because these parts are more comfortable to examine in humans.

Keywords: Human dendritic cell subset; dendritic cell classification; immune responses; tolerogenic dendritic cell.

Publication types

  • Review

MeSH terms

  • Autoimmunity
  • Biomarkers / analysis
  • Biomarkers / metabolism
  • Dendritic Cells / classification*
  • Dendritic Cells / immunology
  • Dendritic Cells / metabolism
  • Humans
  • Immune Tolerance

Substances

  • Biomarkers